1. Home
  2. AMWL vs IVA Comparison

AMWL vs IVA Comparison

Compare AMWL & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMWL
  • IVA
  • Stock Information
  • Founded
  • AMWL 2006
  • IVA 2011
  • Country
  • AMWL United States
  • IVA France
  • Employees
  • AMWL N/A
  • IVA N/A
  • Industry
  • AMWL Retail: Computer Software & Peripheral Equipment
  • IVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMWL Technology
  • IVA Health Care
  • Exchange
  • AMWL Nasdaq
  • IVA Nasdaq
  • Market Cap
  • AMWL 146.3M
  • IVA 117.3M
  • IPO Year
  • AMWL 2020
  • IVA 2020
  • Fundamental
  • Price
  • AMWL $10.98
  • IVA $2.17
  • Analyst Decision
  • AMWL Hold
  • IVA Strong Buy
  • Analyst Count
  • AMWL 4
  • IVA 4
  • Target Price
  • AMWL $12.50
  • IVA $13.25
  • AVG Volume (30 Days)
  • AMWL 60.7K
  • IVA 6.4K
  • Earning Date
  • AMWL 02-12-2025
  • IVA 09-25-2024
  • Dividend Yield
  • AMWL N/A
  • IVA N/A
  • EPS Growth
  • AMWL N/A
  • IVA N/A
  • EPS
  • AMWL N/A
  • IVA N/A
  • Revenue
  • AMWL $254,035,000.00
  • IVA $20,652,523.00
  • Revenue This Year
  • AMWL N/A
  • IVA N/A
  • Revenue Next Year
  • AMWL $24.96
  • IVA $361.78
  • P/E Ratio
  • AMWL N/A
  • IVA N/A
  • Revenue Growth
  • AMWL N/A
  • IVA N/A
  • 52 Week Low
  • AMWL $5.00
  • IVA $1.53
  • 52 Week High
  • AMWL $29.00
  • IVA $4.50
  • Technical
  • Relative Strength Index (RSI)
  • AMWL 71.54
  • IVA 39.56
  • Support Level
  • AMWL $7.02
  • IVA $2.11
  • Resistance Level
  • AMWL $8.83
  • IVA $2.24
  • Average True Range (ATR)
  • AMWL 0.66
  • IVA 0.07
  • MACD
  • AMWL 0.39
  • IVA 0.01
  • Stochastic Oscillator
  • AMWL 91.25
  • IVA 26.58

About AMWL American Well Corporation

American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: